Skip to content

Drug interactions

Topiramate + Vincristine liposomal

Severity: Minor

Topiramate and Vincristine liposomal: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Vincristine is a CYP3A substrate, and topiramate's weak CYP3A4 induction could theoretically lower its exposure. The effect is expected to be minor compared with strong inducers.

What this interaction means in plain words

Topiramate and Vincristine liposomal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Evidence level: Low

Why it happens

Weak CYP3A4 induction by topiramate may slightly increase vincristine metabolism.

What to do

No dose change is required; monitor treatment response and neurotoxicity as per the chemotherapy regimen.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Topiramate and Vincristine liposomal, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Topiramate with Vincristine liposomal?

MediHelp rates the interaction as minor. Topiramate and Vincristine liposomal have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Vincristine is a CYP3A substrate, and topiramate's weak CYP3A4 induction could theoretically lower its exposure. The effect is expected to be minor compared with strong inducers.

How serious is the interaction between Topiramate and Vincristine liposomal?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is required; monitor treatment response and neurotoxicity as per the chemotherapy regimen.

What other medicines interact with Topiramate?

MediHelp also lists interactions of Topiramate with, for example, Benzhydrocodone / acetaminophen, Buprenorphine long-acting, Buprenorphine subdermal implant. The full list is on the Topiramate page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in